VYOME HOLDINGS, INC. Earnings Per Share, Basic and Diluted
VYOME HOLDINGS, INC. (HIND) reported Earnings Per Share, Basic and Diluted of -$0.47 per share for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-16.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-08-16
- VYOME HOLDINGS, INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.47.
- VYOME HOLDINGS, INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.44.
- VYOME HOLDINGS, INC. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$1.10.
- VYOME HOLDINGS, INC. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.20.
- VYOME HOLDINGS, INC. earnings per share, basic and diluted for fiscal 2020 was -$1.59.
- VYOME HOLDINGS, INC. earnings per share, basic and diluted for fiscal 2019 was -$5.03.
- VYOME HOLDINGS, INC. earnings per share, basic and diluted for fiscal 2018 was -$19.64.
- VYOME HOLDINGS, INC. earnings per share, basic and diluted for fiscal 2017 was -$2.08.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-06-30 | -$0.47 10-Q · filed 2021-08-16 | -$1.11 10-Q · filed 2021-08-16 | -$2.04 derived: net income ÷ weighted average shares · filed 2023-04-17 | -$2.71 derived: net income ÷ weighted average shares · filed 2023-04-17 | ||||
| 2021-03-31 | -$0.44 10-Q · filed 2021-05-12 | -$1.56 derived: net income ÷ weighted average shares · filed 2022-05-23 | -$2.24 derived: net income ÷ weighted average shares · filed 2022-05-23 | -$2.79 derived: net income ÷ weighted average shares · filed 2022-05-23 | ||||
| 2020-12-31 | -$1.10 derived: net income ÷ weighted average shares · filed 2022-04-08 | -$1.77 derived: net income ÷ weighted average shares · filed 2022-04-08 | -$2.32 derived: net income ÷ weighted average shares · filed 2022-04-08 | -$1.59 10-K · filed 2021-03-12 | ||||
| 2020-09-30 | -$0.20 10-Q · filed 2020-11-06 | -$1.20 derived: net income ÷ weighted average shares · filed 2021-11-12 | -$1.42 10-Q · filed 2020-11-06 | |||||
| 2020-06-30 | -$0.52 10-Q · filed 2021-08-16 | -$0.54 10-Q · filed 2020-07-30 | -$1.15 10-Q · filed 2021-08-16 | -$1.22 10-Q · filed 2020-07-30 | ||||
| 2020-03-31 | -$0.68 10-Q · filed 2021-05-12 | |||||||
| 2019-12-31 | -$5.03 10-K · filed 2021-03-12 | |||||||
| 2019-09-30 | -$0.61 10-Q · filed 2020-11-06 | -$5.07 10-Q · filed 2020-11-06 | ||||||
| 2019-06-30 | -$2.52 10-Q · filed 2020-07-30 | -$0.25 10-Q · filed 2019-07-24 | -$6.02 10-Q · filed 2020-07-30 | -$0.60 10-Q · filed 2019-07-24 | ||||
| 2019-03-31 | -$3.59 10-Q · filed 2020-06-19 | -$0.36 10-Q · filed 2019-05-10 | ||||||
| 2018-12-31 | -$0.39 10-K · filed 2019-02-22 | -$19.64 10-K · filed 2020-02-27 | -$1.96 10-K · filed 2019-02-22 | |||||
| 2018-09-30 | -$3.47 10-Q · filed 2019-11-08 | -$0.35 10-Q · filed 2018-11-02 | -$16.05 10-Q · filed 2019-11-08 | -$1.60 10-Q · filed 2018-11-02 | ||||
| 2018-06-30 | -$0.57 10-Q · filed 2019-07-24 | -$1.29 10-Q · filed 2019-07-24 | ||||||
| 2018-03-31 | -$0.71 10-Q · filed 2019-05-10 | |||||||
| 2017-12-31 | -$0.60 10-K · filed 2019-02-22 | -$2.08 10-K · filed 2019-02-22 | ||||||
| 2017-09-30 | -$0.55 10-K · filed 2019-02-22 | -$1.48 10-Q · filed 2018-11-02 | ||||||
| 2017-06-30 | -$0.46 10-K · filed 2019-02-22 | -$0.93 10-Q · filed 2018-08-02 | ||||||
| 2017-03-31 | -$0.47 10-K · filed 2019-02-22 | |||||||
| 2016-12-31 | -$0.51 10-K · filed 2018-03-05 | -$4.85 10-K · filed 2018-03-05 | ||||||
| 2016-09-30 | -$5.46 10-K · filed 2018-03-05 | -$18.36 10-Q · filed 2017-11-03 | ||||||
| 2016-06-30 | -$7.15 10-K · filed 2018-03-05 | -$13.37 10-Q · filed 2017-08-02 | ||||||
| 2016-03-31 | -$6.22 10-K · filed 2018-03-05 | |||||||
| 2015-12-31 | -$8.42 10-K · filed 2017-02-23 | -$27.14 10-K · filed 2018-03-05 | ||||||
| 2015-09-30 | -$6.21 10-K · filed 2017-02-23 | -$18.71 10-Q · filed 2016-11-10 | ||||||
| 2015-06-30 | -$8.75 10-K · filed 2017-02-23 | |||||||
| 2015-03-31 | -$3.74 10-K · filed 2017-02-23 | |||||||
| 2014-12-31 | -$18.61 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |